Advanced Research on Genomic Instability and Gene Expression in Developmental Disorders
A special issue of Cells (ISSN 2073-4409).
Deadline for manuscript submissions: 20 December 2025 | Viewed by 73
Special Issue Editor
Interests: human genetics; neurological diseases; neurodegeneration; human molecular genetics; multiple sclerosis; seizures; neurodevelopmental disorders; Parkinson's disease; neurodegenerative diseases
Special Issue Information
Dear Colleagues,
Genomic instability and abnormalities in gene expression can disrupt normal development, leading to a variety of disorders, including neurodevelopmental diseases, epilepsy, metabolic disorders, and cancer. A comprehensive understanding of genetic alterations, epigenetic modifications, and their functional consequences is essential for advancing our knowledge of developmental disorders. Research into genomic instability and gene expression will not only provide insights into the molecular and cellular mechanisms underlying these conditions but also inform strategies for diagnosis and therapeutic interventions.
This Special Issue invites contributions of original research articles, reviews, or perspective articles on all aspects of genomic instability and gene expression in developmental disorders across various model systems. Relevant topics include, but are not limited to, genetic and epigenetic changes, as well as the molecular and cellular mechanisms underlying developmental disorders. Studies that provide insights into disease diagnosis and treatment are highly encouraged.
Dr. Shenzhao Lu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- development
- neurological disease
- cancer
- genetic
- epigenetic
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
